|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Yang L, Parkin DM, Li LD, Chen YD and Bray
F: Estimation and projection of the national profile of cancer
mortality in China: 1991–2005. Br J Cancer. 90:2157–2166.
2004.PubMed/NCBI
|
|
3
|
Howe HL, Wingo PA, Thun MJ, Ries LA,
Rosenberg HM, Feigal EG and Edwards BK: Annual report to the nation
on the status of cancer (1973 through 1998), featuring cancers with
recent increasing trends. J Natl Cancer Inst. 93:824–842. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Little AG, Gay EG, Gaspar LE and Stewart
AK: National survey of non-small cell lung cancer in the United
States: epidemiology, pathology and patterns of care. Lung Cancer.
57:253–260. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Thun MJ: Cancer statistics, 2006. CA Cancer J Clin.
56:106–130. 2006. View Article : Google Scholar
|
|
6
|
Steeg PS, Bevilacqua G, Kopper L,
Thorgeirsson UP, Talmadge JE, Liotta LA and Sobel ME: Evidence for
a novel gene associated with low tumor metastatic potential. J Natl
Cancer Inst. 80:200–204. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen JJ, Peck K, Hong TM, Yang SC, Sher
YP, Shih JY, Wu R, et al: Global analysis of gene expression in
invasion by a lung cancer model. Cancer Res. 61:5223–5230.
2001.PubMed/NCBI
|
|
8
|
Nakamura N, Kobayashi K, Nakamoto M, Kohno
T, Sasaki H, Matsuno Y and Yokota J: Identification of tumor
markers and differentiation markers for molecular diagnosis of lung
adenocarcinoma. Oncogene. 25:4245–4255. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tian T, Hao J, Xu A, Hao J, Luo C, Liu C,
Huang L, Xiao X and He D: Determination of metastasis-associated
proteins in non-small cell lung cancer by comparative proteomic
analysis. Cancer Sci. 98:1265–1274. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen G, Gharib TG, Huang CC, Thomas DG,
Shedden KA, Taylor JM, Kardia SL, et al: Proteomic analysis of lung
adenocarcinoma: identification of a highly expressed set of
proteins in tumors. Clin Cancer Res. 8:2298–2305. 2002.PubMed/NCBI
|
|
11
|
Chen G, Gharib TG, Thomas DG, Huang CC,
Misek DE, Kuick RD, Giordano TJ, et al: Proteomic analysis of
eIF-5A in lung adenocarcinomas. Proteomics. 3:496–504. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rho JH, Roehrl MH and Wang JY: Tissue
proteomics reveals differential and compartment-specific expression
of the homologs transgelin and transgelin-2 in lung adenocarcinoma
and its stroma. J Proteome Res. 8:5610–5618. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YF, Xiao ZQ, Li MX, Li MY, Zhang PF,
Li C, Li F, et al: Quantitative proteome analysis reveals annexin
A3 as a novel biomarker in lung adenocarcinoma. J Pathol.
217:54–64. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu YF, Zhang PF, Li MY, Li QQ and Chen
ZC: Identification of annexin A1 as a proinvasive and prognostic
factor for lung adenocarcinoma. Clin Exp Metastasis. 28:413–425.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Emmott E, Wise H, Loucaides EM, Matthews
DA, Digard P and Hiscox JA: Quantitative proteomics using SILAC
coupled to LC-MS/MS reveals changes in the nucleolar proteome in
influenza A virus-infected cells. J Proteome Res. 9:5335–5345.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qattan AT, Mulvey C, Crawford M, Natale DA
and Godovac-Zimmermann J: Quantitative organelle proteomics of
MCF-7 breast cancer cells reveals multiple subcellular locations
for proteins in cellular functional processes. J Proteome Res.
9:495–508. 2010. View Article : Google Scholar
|
|
17
|
Wu CC, MacCoss MJ, Howell KE and Yates JR
III: A method for the comprehensive proteomic analysis of membrane
proteins. Nat Biotechnol. 21:532–538. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wu CC and Yates JR III: The application of
mass spectrometry to membrane proteomics. Nat Biotechnol.
21:262–267. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dowling P, Meleady P, Dowd A, Henry M,
Glynn S and Clynes M: Proteomic analysis of isolated membrane
fractions from superinvasive cancer cells. Biochim Biophys Acta.
1774:93–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liang X, Zhao J, Hajivandi M, Wu R, Tao J,
Amshey JW and Pope RM: Quantification of membrane and
membrane-bound proteins in normal and malignant breast cancer cells
isolated from the same patient with primary breast carcinoma. J
Proteome Res. 5:2632–2641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Stockwin LH, Blonder J, Bumke MA, Lucas
DA, Chan KC, Conrads TP, Issaq HJ, et al: Proteomic analysis of
plasma membrane from hypoxia-adapted malignant melanoma. J Proteome
Res. 5:2996–3007. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Slamon DJ, Leyland-Jones B, Shak S, Fuchs
H, Paton V, Bajamonde A, Fleming T, et al: Use of chemotherapy plus
a monoclonal antibody against HER2 for metastatic breast cancer
that overexpresses HER2. N Engl J Med. 344:783–792. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Oh P, Li Y, Yu J, Durr E, Krasinska KM,
Carver LA, Testa JE and Schnitzer JE: Subtractive proteomic mapping
of the endothelial surface in lung and solid tumors for
tissue-specific therapy. Nature. 429:629–635. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cao R, Li X, Liu Z, Peng X, Hu W, Wang X,
Chen P, et al: Integration of a two-phase partition method into
proteomics research on rat liver plasma membrane proteins. J
Proteome Res. 5:634–642. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao Z, Li G, Chen Y, Li M, Peng F, Li C,
Li F, et al: Quantitative proteomic analysis of formalin-fixed and
paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling,
two-dimensional liquid chromatography, and tandem mass
spectrometry. J Histochem Cytochem. 58:517–527. 2010. View Article : Google Scholar
|
|
26
|
Krogh A, Larsson B, von Heijne G and
Sonnhammer EL: Predicting transmembrane protein topology with a
hidden Markov model: application to complete genomes. J Mol Biol.
305:567–580. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kyte J and Doolittle RF: A simple method
for displaying the hydropathic character of a protein. J Mol Biol.
157:105–132. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cheng AL, Huang WG, Chen ZC, Peng F, Zhang
PF, Li MY, Li F, et al: Identification of novel nasopharyngeal
carcinoma biomarkers by laser capture microdissection and proteomic
analysis. Clin Cancer Res. 14:435–445. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tarone G, Hirsch E, Brancaccio M, De
Acetis M, Barberis L, Balzac F, Retta SF, et al: Integrin function
and regulation in development. Int J Dev Biol. 44:725–731.
2000.PubMed/NCBI
|
|
30
|
Hollenbeck ST, Itoh H, Louie O, Faries PL,
Liu B and Kent KC: Type I collagen synergistically enhances
PDGF-induced smooth muscle cell proliferation through
pp60src-dependent crosstalk between the α2β1 integrin
and PDGFβ receptor. Biochem Biophys Res Commun. 325:328–337. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Moro L, Venturino M, Bozzo C, Silengo L,
Altruda F, Beguinot L, Tarone G and Defilippi P: Integrins induce
activation of EGF receptor: role in MAP kinase induction and
adhesion-dependent cell survival. EMBO J. 17:6622–6632. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bhowmick NA, Zent R, Ghiassi M, McDonnell
M and Moses HL: Integrin β1 signaling is necessary for transforming
growth factor-β activation of p38MAPK and epithelial plasticity. J
Biol Chem. 276:46707–46713. 2001.
|
|
33
|
Frish SM and Francis H: Disruption of
epithelial cell-matrix interaction induces apoptosis. J Cell Biol.
124:619–626. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Aoudjit F and Vuori K: Integrin signaling
inhibits paclitaxel-induced apoptosis in breast cancer cells.
Oncogene. 20:4995–5004. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yamada KM, Kennedy DW, Yamada SS, Gralnick
H, Chen WT and Akiyama SK: Monoclonal antibody and synthetic
peptide inhibitors of human tumor cell migration. Cancer Res.
50:4485–4496. 1990.PubMed/NCBI
|
|
36
|
Bredin CG, Sundqvist KG, Hauzenberger D
and Klominek J: Integrin dependent migration of lung cancer cells
to extracellular matrix components. Eur Respir J. 11:400–407. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ju LX, Zhou CC, Li W and Yan LH: Integrin
beta1 over-expression associates with resistance to tyrosine kinase
inhibitor gefitinib in non-small cell lungcancer. J Cell Biochem.
111:1565–1574. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zhao G, Cui J, Qin Q, Zhang J, Liu L, Deng
S, Wu C, et al: Mechanical stiffness of liver tissues in relation
to integrin β1 expression may influence the development of hepatic
cirrhosis and hepatocellular carcinoma. J Surg Oncol. 102:482–489.
2010.PubMed/NCBI
|
|
39
|
Oshita F, Kameda Y, Ikehara M, Tanaka G,
Yamada K, et al: Increased expression of integrin beta1 is a poor
prognostic factor in small-cell lung cancer. Anticancer Res.
22:1065–1070. 2002.PubMed/NCBI
|
|
40
|
Chang MH, Lee K, Lee KY, Kim YS, Kim YK
and Kang JH: Prognostic role of integrin β1, E-cadherin, and rac1
expression in small cell lung cancer. APMIS. 120:28–38. 2012.
|
